Auzanneau G - Search Results

1

[Role of double induction in the treatment of acute myeloblastic leukemia in the adult: intermediate results of protocol LAM90].

Castaigne S, Archimbaud E, Fenaux P, Bordessoule D, Tilly H, Simon M, Dupriez B, Auzanneau G, Legros M, Tertian G, et al. Castaigne S, et al. Among authors: auzanneau g. Nouv Rev Fr Hematol (1978). 1994 Jul;36 Suppl 2:S139-40. Nouv Rev Fr Hematol (1978). 1994. PMID: 7971262 Clinical Trial. French. No abstract available.

2

Prognostic factors of acute non lymphoblastic leukemia in children and adults. Results from two multicentric trials (705 patients).

Castaigne S, Chevret S, Lepage E, Guilhot F, Fenaux P, Bordessoule D, Tilly H, Auzanneau G, Tertian G, Guy H, et al. Castaigne S, et al. Among authors: auzanneau g. Nouv Rev Fr Hematol (1978). 1990;32(5):297-300. Nouv Rev Fr Hematol (1978). 1990. PMID: 2099400 Clinical Trial.

3

[Sequential chemotherapy with or without GM-CSF in acute myeloid leukemia (AML) in the advanced phase: current status of protocols EMA 86 and EMA 91].

Archimbaud E, Leblond V, Fenaux P, Dombret H, Cordonnier C, Cony-Makoul P, Dreyfus F, Troussard X, Auzanneau G, Stoppa AM, et al. Archimbaud E, et al. Among authors: auzanneau g. Nouv Rev Fr Hematol (1978). 1994 Jul;36 Suppl 2:S145-8. Nouv Rev Fr Hematol (1978). 1994. PMID: 7971264 French. No abstract available.

4

A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group.

Dombret H, Chastang C, Fenaux P, Reiffers J, Bordessoule D, Bouabdallah R, Mandelli F, Ferrant A, Auzanneau G, Tilly H, et al. Dombret H, et al. Among authors: auzanneau g. N Engl J Med. 1995 Jun 22;332(25):1678-83. doi: 10.1056/NEJM199506223322504. N Engl J Med. 1995. PMID: 7539109 Free article. Clinical Trial.

5

Granulocyte-macrophage colony-stimulating factor in association to timed-sequential chemotherapy with mitoxantrone, etoposide, and cytarabine for refractory acute myelogenous leukemia.

Archimbaud E, Fenaux P, Reiffers J, Cordonnier C, Leblond V, Travade P, Troussard X, Tilly H, Auzanneau G, Marie JP, et al. Archimbaud E, et al. Among authors: auzanneau g. Leukemia. 1993 Mar;7(3):372-7. Leukemia. 1993. PMID: 8445942 Clinical Trial.

6

Timed sequential chemotherapy for advanced acute myeloid leukemia.

Archimbaud E, Leblond V, Fenaux P, Dombret H, Cordonnier C, Dreyfus F, Cony-Makhoul P, Tilly H, Troussard X, Auzanneau G, Thomas X, Ffrench M, Marie JP. Archimbaud E, et al. Among authors: auzanneau g. Hematol Cell Ther. 1996 Apr;38(2):161-7. doi: 10.1007/s00282-996-0161-2. Hematol Cell Ther. 1996. PMID: 8931997 Clinical Trial.

7

Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.

Mourad N, Mounier N, Brière J, Raffoux E, Delmer A, Feller A, Meijer CJ, Emile JF, Bouabdallah R, Bosly A, Diebold J, Haioun C, Coiffier B, Gisselbrecht C, Gaulard P; Groupe d'Etude des Lymphomes de l'Adulte. Mourad N, et al. Blood. 2008 May 1;111(9):4463-70. doi: 10.1182/blood-2007-08-105759. Epub 2008 Feb 21. Blood. 2008. PMID: 18292286 Free PMC article. Clinical Trial.

8

Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen.

Bosly A, Coiffier B, Gisselbrecht C, Tilly H, Auzanneau G, Andrien F, Herbrecht R, Legros M, Devaux Y, Jaubert J, et al. Bosly A, et al. Among authors: auzanneau g. J Clin Oncol. 1992 Oct;10(10):1615-23. doi: 10.1200/JCO.1992.10.10.1615. J Clin Oncol. 1992. PMID: 1383435

9

Evaluation of residual masses after lymphoma treatment: the contribution of gallium 67 tomoscintigraphy.

Nedellec G, Lioure B, Bussy E, de Revel T, Carlioz R, Gaillard JF, Auzanneau G. Nedellec G, et al. Among authors: auzanneau g. Nouv Rev Fr Hematol (1978). 1990;32(3):187-90. Nouv Rev Fr Hematol (1978). 1990. PMID: 2216703

10

Successful treatment of adult acute lymphoblastic leukemia after relapse with prednisone, intermediate-dose cytarabine, mitoxantrone, and etoposide (PAME) chemotherapy.

Milpied N, Gisselbrecht C, Harousseau JL, Sebban C, Witz F, Troussard X, Gratecos N, Michallet M, LeBlond V, Auzanneau G, et al. Milpied N, et al. Among authors: auzanneau g. Cancer. 1990 Aug 15;66(4):627-31. doi: 10.1002/1097-0142(19900815)66:4<627::aid-cncr2820660404>3.0.co;2-0. Cancer. 1990. PMID: 2386891

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters